Adverse Events Among Hospitalized Patients in China
1 other identifier
observational
2,807
1 country
1
Brief Summary
The goal of this observational study is to learn about the incidence and characteristics of adverse events (AEs) among hospitalized patients in China and to compare 4 commonly used methods for detecting these events. The main questions it aims to answer are: How common are AEs among hospitalized patients, and what are their characteristics (types, severity, and preventability) in China? How do 4 commonly used methods, including the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs), compare in detecting AEs? Researchers review randomly selected medical records from 5 hospitals in China to identify AEs, assess their type, severity, and preventability, and evaluate the performance of the 4 detection methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2026
CompletedFirst Submitted
Initial submission to the registry
July 6, 2026
CompletedFirst Posted
Study publicly available on registry
July 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
ExpectedJuly 15, 2026
July 1, 2026
7 months
July 6, 2026
July 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adverse event incidence
The proportion of admissions with at least one adverse event.
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge.
Secondary Outcomes (7)
Types of adverse event
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
Preventability of adverse event
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
Severity of adverse events
During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge
Sensitivity of adverse event detection methods
After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
Specificity of adverse event detection methods
After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions
- +2 more secondary outcomes
Interventions
This is a retrospective cross-sectional study based on medical record review. The study assesses AE incidence and characteristics and compares AE detection methods, with no intervention administered to participants.
Eligibility Criteria
The study population consisted of inpatient admissions to 5 participating public general hospitals in Beijing, China, during 2024. Eligible admissions were identified according to predefined inclusion and exclusion criteria. Stratified random sampling was used, with sample sizes allocated in proportion to hospital admission volumes. Within each site, eligible admissions were randomly selected with equal selection probabilities. The final study sample included 2,843 admissions.
You may qualify if:
- age ≥18 years and a length of stay of at least 24 hours
You may not qualify if:
- Patients admitted primarily for psychiatric disorders, palliative care, or rehabilitation were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking Union Medical College Hospitallead
- Beijing No.6 Hospitalcollaborator
- Beijing Longfu Hospitalcollaborator
- Beijing Puren Hospitalcollaborator
- Beijing Hepingli Hospitalcollaborator
Study Sites (1)
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College
Beijing, Beijing Municipality, 100730, China
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 6, 2026
First Posted
July 15, 2026
Study Start
August 28, 2025
Primary Completion
March 11, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
July 15, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share